SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-047882
Filing Date
2023-04-20
Accepted
2023-04-20 17:19:38
Documents
1
Period of Report
2023-04-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2311973-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2311973-3_4seq1.xml 4 6644
  Complete submission text file 0001104659-23-047882.txt   8131
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Issuer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JAGUAR HEALTH INC., 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address
Chaturvedi Pravin R (Reporting) CIK: 0001916935 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36714 | Film No.: 23833975